Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

NCT ID: NCT03771508

Last Updated: 2025-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3712 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-13

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational, Multicenter, Post-market, Minimal risk, Prospective data collection of PillCam SB3 videos (including PillCam reports) and raw data files and optional collection of Eneteroscopy reports

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Up to 8000 PillCam SB3 videos (including PillCam reports) and raw data files will be collected in up to 50 medical centers in the US. Study duration is up to 7 years from IRB approval.

Medical center study sites will provide relevant videos (including PillCam reports) and raw data from patients who underwent SB3 procedures.

Per patient demographic data will be also collected to provide a description of the study population characteristics and disposition.

Additional Standard of care data collection might be performed (optional). This data will include a de-identified Eneteroscopy report, from patients enrolled to the study and referred to Eneteroscopy procedure (all types of Eneteroscopies), following findings identified during the PillCamTM SB procedure, as part of the standard of care procedure. This data might be collected retrospectively for enrolled patients who underwent an Eneteroscopy procedure. The de-identified reports will be used by MDT GI research and development team to further develop and validated SB capsule localization.

Study subjects will not undergo any additional procedures, nor will their diagnosis and subsequent treatment pathway be changed for the purpose of the registry.

The data will be used by MDT GIs research and development team for the development and validation of improved and new detectors in the PillCam software.

The videos (including PillCam reports) and raw data files will be de-identified at the medical center by representatives who are authorized and delegated to review medical records, prior to providing them to the sponsor. All data in the study- videos, reports, raw data files and demographic information will be de-identified in a manner that is untraceable by the sponsor clinical study team members.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Small Intestine Disease Small Intestine Cancer Small Intestinal Ulcer Bleeding Small Intestine Obstruction Small Intestine Adenocarcinoma Small Intestine Polyp

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PillCam SB3 procedure

Subjects with normal/abnormal PillCam SB3 procedure

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All SB3 cases collected during standard of care procedures.
* The subject received an explanation and understands the nature of the study and provided oral consenting

Exclusion Criteria

* None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic - MITG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melanie Sojourner

Role: STUDY_DIRECTOR

Medtronic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham Gastroenterology Associates

Birmingham, Alabama, United States

Site Status

Gastroenterology & Liver Institute

Escondido, California, United States

Site Status

Amicis Research Center

Valencia, California, United States

Site Status

Medical Research Center of Connecticut

Hamden, Connecticut, United States

Site Status

Encore Borland-Groover

Jacksonville, Florida, United States

Site Status

Research Associates of South Florida

Miami, Florida, United States

Site Status

University of Miami Miller School of Medicine

Miami, Florida, United States

Site Status

Digestive Healthcare of GA

Atlanta, Georgia, United States

Site Status

The University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Capital Digestive Care

Chevy Chase, Maryland, United States

Site Status

Gastro Center of Maryland

Columbia, Maryland, United States

Site Status

Woodholme Gastroenterology Associates

Pikesville, Maryland, United States

Site Status

UMass Memorial Health Care

Worcester, Massachusetts, United States

Site Status

Digestive Health Associates

Farmington Hills, Michigan, United States

Site Status

Clinical Research Professionals

Chesterfield, Missouri, United States

Site Status

The Children's Mercy Hospital

Kansas City, Missouri, United States

Site Status

Atlantic Digestive Health Institute

Morristown, New Jersey, United States

Site Status

Albany Gastroenterology Consultants

Albany, New York, United States

Site Status

Erber M.D. PC

Brooklyn, New York, United States

Site Status

Northwell Health - Cohen Children's Medical Center of New York

Lake Success, New York, United States

Site Status

New York Gastroenterology Associates

New York, New York, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

The Toledo Clinic

Toledo, Ohio, United States

Site Status

Digestive Disease Specialists Inc

Oklahoma City, Oklahoma, United States

Site Status

USDH Clinical Research

Exton, Pennsylvania, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

Rhode Island Hospital

Providence, Rhode Island, United States

Site Status

Palmetto Primary Care

Summerville, South Carolina, United States

Site Status

Austin Gastro

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDT18014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.